Acceptability of Genetic Testing for Paget's Disease
Author Information
Author(s): Anne L Langston, Marie Johnston, Clare Robertson, Marion K Campbell, Vikki A Entwistle, Theresa M Marteau, Marilyn McCallum, Stuart H Ralston
Primary Institution: Health Services Research Unit, University of Aberdeen
Hypothesis
Would relatives of people with Paget's disease want testing and treatment if they were available?
Conclusion
The study aims to understand factors influencing the acceptability of genetic testing and preventative treatment for Paget's disease among relatives.
Supporting Evidence
- Paget's disease affects about 3% of individuals over the age of 55 years in the UK.
- Genetic factors play a significant role in Paget's disease.
- Effective treatments exist that could prevent or delay the onset of Paget's disease.
Takeaway
This study is trying to find out if family members of people with Paget's disease would be interested in genetic testing and treatment to prevent the disease.
Methodology
Semi-structured interviews with individuals suffering from Paget's disease and their relatives.
Potential Biases
Potential biases in self-reported beliefs and perceptions about genetic testing and treatment.
Limitations
The study may not include non-English speakers and those with limited life expectancy.
Participant Demographics
Participants include individuals with Paget's disease and their first and second-degree relatives.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website